Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3029% below fair value
$20.95+0.12 (+0.58%)
Close on Nov 18, 2026Market cap $7.49BP/E –Yield –
Bausch & Lomb operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Bausch & Lomb's operating income for the twelve months ending Sep 30, 2026 was $383.00M, up 335.2% year over year. For fiscal 2025 it was $113.00M, down 30.2% from the year before. The highest annual figure on record is $329.00M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.00M | -30.2% |
| FY2024 | Dec 31, 2024 | $162.00M | +24.6% |
| FY2023 | Dec 31, 2023 | $130.00M | -37.2% |
| FY2022 | Dec 31, 2022 | $207.00M | -37.1% |
| FY2021 | Dec 31, 2021 | $329.00M | +26.5% |
| FY2020 | Dec 31, 2020 | $260.00M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $155.00M | +63.2% |
| Q2 FY2026 | Jun 30, 2026 | $83.00M | – |
| Q1 FY2026 | Mar 31, 2026 | $33.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $112.00M | +28.7% |
| Q3 FY2025 | Sep 30, 2025 | $95.00M | +120.9% |
| Q2 FY2025 | Jun 30, 2025 | -$11.00M | -142.3% |
| Q1 FY2025 | Mar 31, 2025 | -$83.00M | -1483.3% |
| Q4 FY2024 | Dec 31, 2024 | $87.00M | +77.6% |
| Q3 FY2024 | Sep 30, 2024 | $43.00M | +7.5% |
| Q2 FY2024 | Jun 30, 2024 | $26.00M | -39.5% |
| Q1 FY2024 | Mar 31, 2024 | $6.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $49.00M | -3.9% |
| Q3 FY2023 | Sep 30, 2023 | $40.00M | -13.0% |
| Q2 FY2023 | Jun 30, 2023 | $43.00M | -23.2% |
| Q1 FY2023 | Mar 31, 2023 | -$2.00M | -103.7% |
| Q4 FY2022 | Dec 31, 2022 | $51.00M | -44.6% |
| Q3 FY2022 | Sep 30, 2022 | $46.00M | -51.1% |
| Q2 FY2022 | Jun 30, 2022 | $56.00M | -3.4% |
| Q1 FY2022 | Mar 31, 2022 | $54.00M | -36.5% |
| Q4 FY2021 | Dec 31, 2021 | $92.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $94.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $58.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $85.00M | – |
See a number that looks wrong?